All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Tax is produced by members of the retroviral family primate T-lymphotropic virus, which are classified as Deltaretroviruses.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L109 | Human anti-tax (LLFGYPVYV) T Cell Receptor, pMP71 | HTLV-1 | Human | LLFGYPVYV | retroviral vector | |||
TCR-L110 | Mouse anti-tax T Cell Receptor,pLXSN | HTLV-1 | Mouse | HLA-A2 | retroviral vector | |||
TCR-L108Z | Human anti-Tax (aa11-19) T cell receptor (Single-chain TCR), pCDTCR1 | HTLV-1 | Human | LLFGYPVYV | Lentiviral | |||
TCR-L109Z | Mouse anti-Tax T cell receptor (Cysteine-modified), pCDTCR1 | HTLV-1 | Mouse | HLA-A2 | Lentiviral | |||
TCR-L110Z | Human anti-Tax (SLYNTVATL) T cell receptor (Single-chain TCR), pCDTCR1 | HTLV-1 | Human | SLYNTVATL | Lentiviral | |||
TCR-C244Z | Human anti-Tax T cell receptor (B7), pCDTCR1 | HTLV-1 | B7 | Human | LLFGYPVYV | HLA-A*0201 | Lentiviral | |
TCR-L130 | Human anti-TAX T cell receptor (S4-3), pCDTCR1 | HTLV-1 | S4-3 | Human | LLFGYPVYV | HLA-A2 | Lentiviral | |
TCR-L131 | Human anti-TAX T cell receptor (A6), pCDTCR1 | HTLV-1 | A6 | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L132 | Human anti-TAX T cell receptor (A6c134M), pCDTCR1 | HTLV-1 | A6c134M | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L133 | Human anti-TAX T cell receptor (A6c134S), pCDTCR1 | HTLV-1 | A6c134S | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L134 | Human anti-TAX T cell receptor (A6c134AE), pCDTCR1 | HTLV-1 | A6c134AE | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L135 | Human anti-TAX T cell receptor (A6c134E), pCDTCR1 | HTLV-1 | A6c134E | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L136 | Human anti-TAX T cell receptor (A6c134R), pCDTCR1 | HTLV-1 | A6c134R | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-L137 | Human anti-TAX T cell receptor (A6c134), pCDTCR1 | HTLV-1 | A6c134 | Human | LLFGYPVYV | HLA-A0201 | Lentiviral | |
TCR-YC1134 | Human anti-Tax T cell receptor ((A6)-1), pCDTCR1 | HTLV1 | A6 | Human | LLFGFAVYV + SCM(F5) | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1135 | Human anti-Tax T cell receptor ((A6)-2), pCDTCR1 | HTLV1 | A6 | Human | LLFGFPVFV + SCM(F5) | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1136 | Human anti-Tax T cell receptor ((A6)-3), pCDTCR1 | HTLV1 | A6 | Human | LLFGFPVYV | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1137 | Human anti-Tax T cell receptor ((A6)-4), pCDTCR1 | HTLV1 | A6 | Human | LLFGFPVYV + SCM(F5) | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1138 | Human anti-Tax T cell receptor ((A6)-5), pCDTCR1 | HTLV1 | A6 | Human | LLFGKPVYV + SCM(K5) | HLA-A*02:01 | Lentiviral vector | |
TCR-YC1139 | Human anti-Tax T cell receptor ((A6)-6), pCDTCR1 | HTLV1 | A6 | Human | LLFGYAVYV | HLA-A*02:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION